Pentraxin 3 as a Prognostic Biomarker in Patients with Systemic Inflammation or InfectionReport as inadecuate




Pentraxin 3 as a Prognostic Biomarker in Patients with Systemic Inflammation or Infection - Download this document for free, or read online. Document in PDF available to download.

Mediators of Inflammation - Volume 2014 2014, Article ID 421429, 9 pages -

Review Article

Department of Critical Care Medicine, Provincial Hospital Affiliated to Shandong University, Jinan 250021, China

Department of Emergency, Zaozhuang Municipal Hospital, Zaozhuang, Shandong 277101, China

Department of Critical Care Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China

Department of Internal Medicine, Rongcheng Traditional Hospital, Weihai 264300, China

Received 4 August 2014; Accepted 7 October 2014; Published 3 November 2014

Academic Editor: Vinod K. Mishra

Copyright © 2014 Siguan Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose. The long pentraxin 3 PTX3 is a key component of the humoral arm of the innate immune system. PTX3 is produced locally in response to proinflammatory stimuli. We reviewed the usefulness of systemic levels of PTX3 in critically ill patients with systemic inflammatory response syndrome SIRS, sepsis, and bacteremia, focusing on its diagnostic and prognostic value. Methods. A PubMed search on PTX3 was conducted. The list of papers was narrowed to original studies of critically ill patients. Eleven papers on original studies of critically ill patients that report on PTX3 in SIRS, sepsis, or bacteremia were identified. Results. Systematic levels of PTX3 have little diagnostic value in critically ill patients with SIRS, sepsis, or bacteremia. Systemic levels of PTX3, however, have superior prognostic power over other commonly used biological markers in these patients. Systemic levels of PTX3 correlate positively with markers of organ dysfunction and severity-of-disease classification system scores. Finally, systemic levels of PTX3 remain elevated in the acute phase and decreased on recovery. Notably, the age of the patients and underlying disease affect systemic levels of PTX3. Conclusions. The diagnostic value of PTX3 is low in patients with sepsis. Systemic levels of PTX3 have prognostic value and may add to prognostication of patients with SIRS or sepsis, complementing severity-of-disease classification systems and other biological markers.





Author: Siguan Liu, Xin Qu, Feng Liu, and Chunting Wang

Source: https://www.hindawi.com/



DOWNLOAD PDF




Related documents